ALR Target Identification in Lupus - 2011 Grantees

In 2011, the ALR is committing funding to 10 Target Identification in Lupus (TIL) grants.  Most TIL investigators are receiving research grants of approximately $400,000 over two years. The ALR is also proud to provide ongoing support for researchers in their second year of TIL funding and for additional, extended TIL projects.

Below is a list of 2011 Grantees:

Barnes, Betsy, PhD   
UMDNJ-New Jersey Medical School
Targeting IRF5 activation for the treatment of lupus 

Craft, Joseph, MD   
Yale University
Follicular Helper T Cells in SLE: Characterization and Therapeutic Targets    

Datta, Syamal, MBBS   
Northwestern University - Chicago Campus  
Peptide Vaccine Suppressing Autoantigen-Specific Response in Human Lupus      

Denny, Michael, PhD  
Temple University
Abnormal Neutrophil Development in SLE   

Diamond, Betty, MD  
The Feinstein Institute for Medical Research
Dendritic cell dysfunction as a path to SLE     

Fu, Shu Man, MD, PhD   
University of Virginia
Progressions and Biomarkers of Proliferative Lupus Nephritis    

Jefferies, Caroline, PhD   
Royal College of Surgeons in Ireland
Ro52 and Siglec-E as therapeutic targets in SLE   

Kaplan, Mariana, MD   
University of Michigan
Lupus and the inflammasome  

Pillai, Shiv, PhD, MBBS   
Massachusetts General Hospital
Targeting the SIAE pathway in lupus

Pisetsky, David, MD
Duke University Medical Center, NC
Nucleic acid binding polymers in the treatment of lupus

Sharma, Shruty, PhD   
University of Massachusetts Medical School
Innate sensing of AT-rich DNA during autoimmunity 

2010 TIL Grantees